Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity

Neuroscience
Frank GillardonH Draheim

Abstract

Mutations in leucine-rich repeat kinase 2 (LRRK2) have been causally linked to neuronal cell death in Parkinson's disease. LRRK2 expression has also been detected in B lymphocytes and macrophages, suggesting a role in immune responses. In the present study, we demonstrate that LRRK2 is expressed in primary microglial cells isolated from brains of adult mice. Moreover, lipopolysaccharide (LPS)-activated microglial cells from mice overexpressing the Parkinson's disease-linked LRRK2(R1441G) mutation exhibit increased expression and secretion of proinflammatory cytokines compared with wild-type control microglia. Expression of the LPS receptor Toll-like receptor 4 (TLR4) and downstream signaling proteins did not differ between LRRK2(R1441G) transgenic microglia and wild-type controls. Consistently, conditioned medium from LPS-stimulated LRRK2(R1441G) transgenic microglia induced significant cell death when added to neuronal cultures. These findings indicate that enhanced neuroinflammation may contribute to neurodegeneration in Parkinson's disease patients carrying LRRK2 mutations.

References

Jul 14, 2006·Journal of Neurochemistry·Asa Abeliovich, M Flint Beal
Jun 3, 2008·Nature Methods·Ali MortazaviBarbara Wold
Oct 24, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tamy C Frank-CannonMalú G Tansey
Nov 27, 2008·Nucleic Acids Research·T J P HubbardP Flicek
Mar 6, 2009·Genome Biology·Ben LangmeadSteven L Salzberg
Jun 2, 2009·Nature Reviews. Drug Discovery·Matthias GaestelMichael Kracht
Jan 26, 2010·Journal of Neuroscience Methods·Simon Moussaud, Henning Joerg Draheim
Mar 4, 2010·Neuro-degenerative Diseases·Christian WiderZbigniew K Wszolek
Sep 30, 2010·Molecular & Cellular Proteomics : MCP·Andrea MeixnerMarius Ueffing

❮ Previous
Next ❯

Citations

Nov 30, 2012·Journal of Neuroinflammation·Daniel F MarkerHarris A Gelbard
May 19, 2012·Journal of Neuroinflammation·Elisa GreggioLuigi Bubacco
May 16, 2013·PloS One·Florian GiesertWolfgang Wurst
Aug 13, 2013·PloS One·Zoë BichlerEng King Tan
Jan 25, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Francesca L'EpiscopoBianca Marchetti
Mar 25, 2014·Journal of Neuroinflammation·Isabella RussoElisa Greggio
Jan 17, 2014·Journal of Molecular Cell Biology·Francesca L'EpiscopoBianca Marchetti
Jan 1, 2014·Molekuliarnaia biologiia·S N PchelinaT S Usenko
Jun 5, 2013·Neurochemical Research·Hardy J Rideout, Leonidas Stefanis
Jul 9, 2013·Molecular Neurobiology·Kazuhiro A FujitaRudi Balling
May 15, 2013·Cellular and Molecular Life Sciences : CMLS·Michela Deleidi, Thomas Gasser
Nov 19, 2015·Acta Neuropathologica·Corinna BliederhaeuserKarin M Danzer
Jun 8, 2014·Experimental Neurology·A Raquel EstevesSandra M Cardoso
May 23, 2014·Journal of Clinical Laboratory Analysis·Enzhu JiangHao Pang
Sep 5, 2012·Trends in Pharmacological Sciences·Janelle Drouin-Ouellet, Francesca Cicchetti
Apr 3, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Matthew D WalkerVesna Sossi
Aug 30, 2012·Journal of Neuroscience Research·Khanh Vinh Quôc Luong, Lan Thi Hoàng Nguyên
Oct 16, 2015·Translational Neurodegeneration·Qinqin WangJiawei Zhou
Apr 22, 2015·Journal of Neural Transmission·Dorit TrudlerDan Frenkel
Apr 12, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cristina Palomo-GaroJavier Fernández-Ruiz
Apr 23, 2015·The FEBS Journal·Rebecca WallingsRina Bandopadhyay
Jun 7, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Priscilla De RosaEnza Maria Valente
Sep 20, 2012·Biochemical Society Transactions·Giovanna SannaCiro Iaccarino
Sep 20, 2012·Biochemical Society Transactions·Nicolas Dzamko, Glenda M Halliday
Sep 20, 2012·Biochemical Society Transactions·Claudia Manzoni
Dec 3, 2014·Neuroscience·N DzamkoG M Halliday
Apr 18, 2015·Frontiers in Neuroanatomy·María-Trinidad HerreroSheela Vyas
Sep 15, 2012·Current Biology : CB·Mark R Cookson
May 14, 2014·BioMed Research International·Xiaomin Su, Howard J Federoff
Jan 8, 2013·Neurochemistry International·Juliet M TaylorPeter J Crack
Apr 25, 2016·Progress in Neurobiology·Valerie JoersAnna R Carta
Feb 27, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Nicolas DzamkoGlenda M Halliday

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.